Gene-based tests may improve treatment for people with bipolar disorder
- Written by Klaus Oliver Schubert, Associate Professor of Psychiatry, University of Adelaide
Responsiveness to lithium – the gold standard of bipolar treatment – runs in families. Francisco Gonzalez/unsplash
Bipolar affective disorder (BPAD) affects around 2% of the world’s population, leaving them with bouts of severe depression and episodes of what is commonly referred to as “mania”.
A range of drug...
Read more: Gene-based tests may improve treatment for people with bipolar disorder